Technical Analysis for IGX - IntelGenx Technologies Corp.

Grade Last Price % Change Price Change
A 0.245 8.89% 0.020
IGX closed up 8.89 percent on Friday, April 19, 2024, on 83 percent of normal volume.
Earnings due: May 9
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Gapped Up Strength 0.00%
Narrow Range Bar Range Contraction 8.89%
Inside Day Range Contraction 8.89%
Gapped Up Strength 8.89%
Fell Below 20 DMA Bearish 11.36%
Gapped Down Weakness 11.36%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

IntelGenx Technologies Corp. Description

IntelGenx Technologies Corp., a drug delivery company, focuses on the development of novel oral thin film products for the pharmaceutical market. It offers RIZAPORT, an oral thin film formulation of rizatriptan benzoate for the treatment of acute migraines. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0008/2008 for migraine; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid dependence; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease. It is also developing INT0037/2013, INT0039/2013, and INT0040/2014. The company has co-development and commercialization agreements with RedHill Biopharma Ltd., Par Pharmaceutical Companies, Inc., and Endo Ventures Ltd.; licensing, development, and supply agreement with Tilray, Inc., Gensco Pharma, and Insud Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharma Pharmaceutical Delivery Montreal Drug Pain Disease Cancer Drugs Grain Alzheimer's Disease Drug Delivery Tilray Pharmaceutical Companies Schizophrenia

Is IGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.35
52 Week Low 0.135
Average Volume 16,919
200-Day Moving Average 0.209
50-Day Moving Average 0.220
20-Day Moving Average 0.236
10-Day Moving Average 0.236
Average True Range 0.014
RSI (14) 55.16
ADX 11.75
+DI 37.562
-DI 32.418
Chandelier Exit (Long, 3 ATRs) 0.217
Chandelier Exit (Short, 3 ATRs) 0.253
Upper Bollinger Bands 0.260
Lower Bollinger Band 0.212
Percent B (%b) 0.68
BandWidth 20.398
MACD Line 0.004
MACD Signal Line 0.005
MACD Histogram -0.0015
Fundamentals Value
Market Cap 27.01 Million
Num Shares 110 Million
EPS -0.12
Price-to-Earnings (P/E) Ratio -1.99
Price-to-Sales 25.39
Price-to-Book 11.85
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.245
Resistance 3 (R3) 0.245 0.245 0.245
Resistance 2 (R2) 0.245 0.245 0.245 0.245
Resistance 1 (R1) 0.245 0.245 0.245 0.245 0.245
Pivot Point 0.245 0.245 0.245 0.245 0.245
Support 1 (S1) 0.245 0.245 0.245 0.245 0.245
Support 2 (S2) 0.245 0.245 0.245 0.245
Support 3 (S3) 0.245 0.245 0.245
Support 4 (S4) 0.245